Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

NCT00004052 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: QS21
BIOLOGICAL: bcr-abl peptide vaccine

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]